Subscribe to RSS
DOI: 10.1055/s-2002-32079
© Georg Thieme Verlag Stuttgart · New York
Mechanism of Endothelium-Dependent Vasodilation Induced by a Proanthocyanidin-Rich Fraction from Ouratea semiserrata
Publication History
July 24, 2001
November 9, 2001
Publication Date:
07 June 2002 (online)
Abstract
The vasodilator effects of Ouratea semiserrata stem hydroethanolic extract (OSE) and its ethyl acetate fraction (OSR) were evaluated in endothelium-intact aortic rings. OSR produced a more potent vasodilatation (IC50 = 3.5 ± 0.8 μg/ml) than OSE (IC50 > 30 μg/ml). OSR also presented a higher content of total proanthocyanidins (21.8 ± 1.5 %) in comparison to OSE (6.5 ± 0.4 %), suggesting that compounds of this class play a role in the vasorelaxing activity. The vasodilatation mechanism of OSR was further investigated. In endothelium-intact aortic rings, its vasorelaxing effect was completely abolished by L-NAME (300 μM), a nitric oxide (NO) synthase inhibitor, but not by a muscarinic antagonist (atropine, 1 μM) nor by a cyclo-oxygenase inhibitor (indomethacin, 10 μM). The OSR vasodilator effect was completely abolished in endothelium-denuded vessels. Furthermore, OSR did not change the vasodilatation produced by SIN-1, an NO donor, in endothelium-denuded vessels. These findings led us to conclude that OSR, a proanthocyanidin rich fraction of O. semiserrata, induces vasodilatation by a mechanism dependent on endothelium-derived factors, likely NO.
Key words
Ouratea semiserrata - Ochnaceae - proanthocyanidin-rich fraction - vasodilator effects - rat aorta - nitric oxide
References
- 1 Corrêa M P. Dicionário de Plantas Úteis do Brasil e das Exóticas Cultivadas. Vol. 1 - 6 Rio de Janeiro; J Di Giorgio 1974
- 2 Braga F C, Wagner H, Lombardi J A, Oliveira A B. Screening the Brazilian flora for antihypertensive plant species for in vitro angiotensin-I-converting enzyme-inhibiting activity. Phytomedicine. 2000; 245 245-50
- 3 Velandia J R, De Carvalho M G, Braz-Filho R. Novel trichloro- and tetrachloroisoflavones isolated from Ouratea semiserrata . Nat Prod Lett. 1998; 12 191-8
- 4 Delle Monache F, D’Albuquerque I L, Marini-Bettolo G B. Su di una nuova proantocianidina dimera da Ouratea . Ann Chim. 1967; 57 1364-71
- 5 Delle Monache F, Ferrari F, D’Albuquerque I L, Marini-Bettolo G B. Sterechimica delle proantocianidine da Ouratea sp. (Ochnaceae). Farmaco. 1970; 25 96-105
- 6 Hertog M GL, Feskens E JM, Hollman P CH, Katan M B, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993; 342 1007-11
- 7 Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J. 1996; 312 478-81
- 8 Muldoon F M, Kritchevsky S B. Flavonoids and heart disease. Br Med J. 1996; 312 458-9
- 9 Duarte J, Vizcaíno F P, Utrilla P, Jiménez J, Tamargo J, Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen Pharmacol. 1993; 24 857-62
- 10 Herrera M D, Zarzuelo A, Jiménez J, Marhuenda E, Duarte J. Effects of flavonoids on rat aortic smooth musckle contractility: structure-activity relationships. Gen Pharmacol. 1996; 27 273-7
- 11 Fitzpatrick D F, Hirschfield S L, Coffey R G. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol. 1993; 65 774-8
- 12 Anbriambeloson E, Magnier C, Haan-Archipoff G, Lobstein A, Anton R, Beretz A, Stoclet J C. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr. 1998; 128 2324-33
- 13 Lemos V S, Freitas M R, Muller B, Lino Y D, Queiroga C EG, Côrtes S F. Dioclein, a new nitric oxide- and endothlium-dependent vasodilator flavonoid. Eur J Pharmacol. 1999; 386 41-6
- 14 Lüscher T F. The endothelium in hypertension: bystander, target or mediator?. J Hypertens. 1994; 12 S105-116
- 15 Vanhoutte P M, Boulanger C M. Endothlium-dependent responses in hypertension. Hypertens Res. 1995; 18 87-98
- 16 Hiermann A, Kartnig T h, Azzam S. Ein Beitrag zur quantitativen Bestimmung der Procyanidine in Crataegus . Sci Pharm. 1986; 54 331-7
- 17 Middleton E, Kandaswami C, Theoharides T C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000; 52 673-751
- 18 Packer L, Rimbach G, Virgili F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Rad Biology Med. 1999; 27 704-24
- 19 Mombouli J V, Vanhoutte P M. Endothelial dysfunction: from physiology to therapy. J. Mol. Cell. Cardiol.. 1999; 31 61-74
- 20 Moncada S, Palmer R MJ, Higgs E A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43 109-42
- 21 Busse R ., Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res. 1996; 33 181-94
- 22 Rice-Evans C A, Miller N J, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad Biol Med. 1996; 20 933-56
- 23 Andriantsitohaina R, Andriambeloson E, Stoclet J C. Pharmacological approaches of endothelial nitric oxide-dependent vasorelaxation induced by polyphenols from plant extracts. Methods Enzymol. 1999; 301 522-32
Fernão Castro Braga
Faculdade de Farmácia da UFMG
Av. Olegário Maciel 2360
CEP 30.180-112
Belo Horizonte
Brazil
Phone: +55 31 3339-7675
Fax: +55 31 3339-7666
Email: fernao@dedalus.lcc.ufmg.br